179 related articles for article (PubMed ID: 17303500)
21. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
22. Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.
van Houdt IS; Muris JJ; Hesselink AT; Kramer D; Cillessen SA; Moesbergen LM; Vos W; Hooijberg E; Meijer CJ; Kummer JA; Oudejans JJ
Histopathology; 2007 Dec; 51(6):778-84. PubMed ID: 18042067
[TBL] [Abstract][Full Text] [Related]
23. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
24. [Lymphoma genesis in the context of HIV infection].
Besson C; Raphaël M
Ann Med Interne (Paris); 2003 Dec; 154(8):523-8. PubMed ID: 15037828
[TBL] [Abstract][Full Text] [Related]
25. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
26. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
27. Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues.
Ozkal S; Paterson JC; Tedoldi S; Hansmann ML; Kargi A; Manek S; Mason DY; Marafioti T
Pathol Res Pract; 2009; 205(11):781-8. PubMed ID: 19647948
[TBL] [Abstract][Full Text] [Related]
28. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
29. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
[TBL] [Abstract][Full Text] [Related]
30. Relationship between classic Hodgkin lymphoma and overlapping large cell lymphoma investigated by comparative expressed sequence hybridization expression profiling.
Vanhentenrijk V; Vanden Bempt I; Dierickx D; Verhoef G; Wlodarska I; De Wolf-Peeters C
J Pathol; 2006 Oct; 210(2):155-62. PubMed ID: 16874743
[TBL] [Abstract][Full Text] [Related]
31. Loss of CD19 expression in B-cell neoplasms.
Masir N; Marafioti T; Jones M; Natkunam Y; Rüdiger T; Hansmann ML; Mason DY
Histopathology; 2006 Feb; 48(3):239-46. PubMed ID: 16430470
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
[TBL] [Abstract][Full Text] [Related]
33. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
Miles RR; Cairo MS; Satwani P; Zwick DL; Lones MA; Sposto R; Abromovitch M; Tripp S; Angiolillo AL; Roman E; Davenport V; Perkins SL
Br J Haematol; 2007 Aug; 138(4):506-12. PubMed ID: 17659054
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin disease associated with T-cell non-Hodgkin lymphomas: case reports and review of the literature.
Brown JR; Weng AP; Freedman AS
Am J Clin Pathol; 2004 May; 121(5):701-8. PubMed ID: 15151210
[TBL] [Abstract][Full Text] [Related]
37. Increased DNA methyltransferase 1 (DNMT1) gene expression in human lymphomas by fluorescent in situ hybridization.
Qayum I; Ashraf M
J Ayub Med Coll Abbottabad; 2004; 16(4):1-6. PubMed ID: 15762053
[TBL] [Abstract][Full Text] [Related]
38. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
39. [Borderline between Hodgkin and non-Hodgkin lymphomas with unfavorable clinical course: a clinical, histological and immunohistochemical analysis of 33 cases within the German Hodgkin Lymphoma Study].
Bernhards J; Fischer R; Werner M; Hübner K; Schwarze EW; Georgii A
Verh Dtsch Ges Pathol; 1992; 76():159-63. PubMed ID: 1283250
[TBL] [Abstract][Full Text] [Related]
40. Enforced expression of Mixl1 during mouse ES cell differentiation suppresses hematopoietic mesoderm and promotes endoderm formation.
Lim SM; Pereira L; Wong MS; Hirst CE; Van Vranken BE; Pick M; Trounson A; Elefanty AG; Stanley EG
Stem Cells; 2009 Feb; 27(2):363-74. PubMed ID: 19038793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
